Name: Monte Rosa Therapeutics, Inc. (GLUE) Balance Sheet
Creator: FinSpry

Monte Rosa Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Monte Rosa Therapeutics, Inc. (GLUE) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	224.25	232.41	262.83	346.07	41.70
Short-Term Investments	147.90	104.31	207.91	0.00	0.00
Cash & Short-Term Investments	372.15	232.41	262.83	346.07	41.70
Accounts Receivable	0.17	0.51	7.66	0.00	0.10
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	5.12	4.48	2.24	2.60	1.79
Total Current Assets	377.44	236.21	275.89	348.67	43.59
Non-Current Assets
Property, Plant & Equipment (Net)	56.31	62.61	61.91	12.33	4.62
Other Non-Current Assets	4.98	4.93	4.60	5.34	1.16
Total Non-Current Assets	61.29	67.54	66.50	17.66	0.00
Total Assets	438.73	303.76	342.39	366.33	49.38
Current Liabilities
Accounts Payable	17.22	25.75	22.44	6.56	7.07
Short-Term Debt	3.71	0.00	0.00	0.00	0.00
Accrued Liabilities	7.21	5.34	3.94	9.24	1.13
Deferred Revenue	117.23	17.68	0.00	0.00	0.00
Other Current Liabilities	18.79	7.59	5.62	0.84	21.08
Total Current Liabilities	156.95	46.59	25.57	16.64	29.28
Non-Current Liabilities
Long-Term Debt	39.00	42.88	43.87	0.00	0.00
Other Non-Current Liabilities	3.70	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	58.85	45.59	45.41	2.18	0.00
Total Liabilities	215.80	124.51	70.98	18.81	30.34
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.00
Retained Earnings	-438.59	-368.61	-232.25	-122.04	-48.08
Accumulated Other Comprehensive Income	-3.36	-2.72	-1.75	-2.02	-1.06
Additional Paid-in Capital	664.87	547.86	503.70	471.57	0.00
Shares Outstanding	61.51	50.14	49.32	46.54	0.00
Total Stockholders' Equity	222.94	179.25	271.45	347.52	19.04
Total Liabilities & Equity	438.73	303.76	342.39	366.33	0.00